This company listing is no longer active
Invacare (IVCR.Q) Stock Overview
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
IVCR.Q Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Invacare Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.013 |
| 52 Week High | US$1.64 |
| 52 Week Low | US$0.011 |
| Beta | 0.51 |
| 1 Month Change | -10.00% |
| 3 Month Change | -62.60% |
| 1 Year Change | -99.09% |
| 3 Year Change | -99.77% |
| 5 Year Change | -99.92% |
| Change since IPO | -99.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| IVCR.Q | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -10.6% | 4.6% | 1.3% |
| 1Y | -99.1% | 2.1% | 16.7% |
Return vs Industry: IVCR.Q underperformed the US Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: IVCR.Q underperformed the US Market which returned 15.2% over the past year.
Price Volatility
| IVCR.Q volatility | |
|---|---|
| IVCR.Q Average Weekly Movement | 28.2% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IVCR.Q's share price has been volatile over the past 3 months.
Volatility Over Time: IVCR.Q's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1885 | 2,800 | Geoff Purtill | www.invacare.com |
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the Pin Dot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products.
Invacare Corporation Fundamentals Summary
| IVCR.Q fundamental statistics | |
|---|---|
| Market cap | US$512.81k |
| Earnings (TTM) | -US$101.07m |
| Revenue (TTM) | US$741.73m |
Is IVCR.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IVCR.Q income statement (TTM) | |
|---|---|
| Revenue | US$741.73m |
| Cost of Revenue | US$557.69m |
| Gross Profit | US$184.04m |
| Other Expenses | US$285.12m |
| Earnings | -US$101.07m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.66 |
| Gross Margin | 24.81% |
| Net Profit Margin | -13.63% |
| Debt/Equity Ratio | 436.8% |
How did IVCR.Q perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/05/05 22:16 |
| End of Day Share Price | 2023/05/05 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Invacare Corporation is covered by 7 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Labick | CJS Securities, Inc. |
| Constantine Davides | D. Boral Capital LLC. |
| Matthew Mishan | KeyBanc Capital Markets Inc. |